Short description
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Description
SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for patients living with severe rare diseases and cancer. SpringWorks has a differentiated targeted oncology pipeline spanning solid tumors and hematological cancers, including two potentially registrational clinical trials in rare tumor types as well as several programs addressing highly prevalent, genetically defined cancers. SpringWorks’ strategic approach and operational excellence in clinical development have enabled it to rapidly advance its two lead product candidates into late-stage clinical trials while simultaneously entering into multiple shared-value partnerships with innovators in industry and academia to unlock the full potential for its portfolio and create more solutions for patients with cancer.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Stamford, Connecticut, United States, North America
Founded on
January 1, 2017
Exited on
September 12, 2019
Went public on
September 12, 2019
Stock symbol
SWTX
Non-profit?
No
Acquired?
No
Employees count
251-500
Investors
Cannot Access, Blurry Noaccess, Absolutely Noaccess, Noaccessforu, Noway Youcantaccess, Cannot Access, Nopepepe, Nopepepe, Noaccessforu, Noway Youcantaccess, Noaccess, Absolutely Noaccess, Cannot Access, No Way, Noway Youcantaccess, Cannot Access, Noaccess, No Way
Sign in for full access
Founders
Lara S. Sullivan, Yoni Falkson